Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose crossover comparison of formoterol delivered by Concept1 versus Aerolizer in persistent asthma
2006-003225-87Phase 2Completed
- Sponsor
- Novartis
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of formoterol in asthma (2 arms), sponsored by Novartis. Primary endpoint: 12-hour area under the curve of FEV1. Started Nov 2006; status: completed.
02
Drugs
formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on 2006-003225-87.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003225-87.